Serum inflammatory markers in diabetic retinopathy.

@article{Meleth2005SerumIM,
  title={Serum inflammatory markers in diabetic retinopathy.},
  author={Annal D. Meleth and Elvira Agr{\'o}n and Chi-Chao Chan and George F. Reed and K. Dilzith Arora and Gordon A. Byrnes and Karl Csaky and Frederick L. Ferris and Emily Y. Chew},
  journal={Investigative ophthalmology \& visual science},
  year={2005},
  volume={46 11},
  pages={
          4295-301
        }
}
PURPOSE To evaluate the association of serum factors with the severity of diabetic retinopathy and to assess their presence in retinal tissue obtained at autopsy. METHODS The following serum factors of 93 subjects were examined at the National Eye Institute (NEI) clinical center: the chemokines regulated on activation, normal T-cell expressed and presumably secreted (RANTES)/CCL5, epithelial neutrophil activator (ENA)-78/CXCL5, interferon-induced protein (IP)-10/CXCL10, stromal cell-derived… 
Effect of serum cytokines and VEGF levels on diabetic retinopathy and macular thickness
TLDR
Investigating the role of serum inflammatory cytokines and vascular endothelial growth factor (VEGF) in diabetic retinopathy and evaluating their relationship with macular thickness measurements obtained with optical coherence tomography found increased serum levels of VEGF and MCP-1 may act as a key regulator of DR and provide a potential tool for risk assessment in diabetic patients.
Multiplex bead analysis of vitreous and serum concentrations of inflammatory and proangiogenic factors in diabetic patients
TLDR
The results suggest that in diabetics, there is an upregulation of IP-10, MCP-1, and VEGF in the vitreous and an up regulation of MIP-1β, RANTES, andVEGFIn the serum, which support the concept of an angiogenic and inflammatory element in the development of diabetic retinopathy.
TNF-alpha is an independent serum marker for proliferative retinopathy in type 1 diabetic patients.
TNF-Alfa is an Independent Serum Marker for Proliferative Retinopathy in Type 1 Diabetic Patients
TLDR
The association between TNF-a and PDR in type 1 diabetic patients suggests that inflammation might play a role in the pathogenesis of proliferative diabetic retinopathy.
Assessment of biomarkers using multiplex assays in aqueous humor of patients with diabetic retinopathy
TLDR
It is suggested that inflammation and immune response may contribute to the pathogenesis of DR, and these biomarkers may potentially be new therapeutic targets for DR.
High Vitreous Concentration of IL-6 and IL-8, but Not of Adhesion Molecules in Relation to Plasma Concentrations in Proliferative Diabetic Retinopathy
TLDR
The elevated IL-6 and IL-8 levels in vitreous, but not in plasma, are evidence favouring local over systemic inflammation in PDR, and there was imbalance between inflammatory and anti-inflammatory cytokines in the vitreOUS.
Interleukin-4 and melatonin ameliorate high glucose and interleukin-1β stimulated inflammatory reaction in human retinal endothelial cells and retinal pigment epithelial cells
TLDR
The results demonstrated that IL-4 and melatonin inhibited inflammation and angiogenesis triggered by high glucose and IL-1β, which suggests that these immune regulatory factors may be of potential therapeutic value in DR.
Vitreous expression of cytokines and growth factors in patients with diabetic retinopathy—An investigation of their expression based on clinical diabetic retinopathy grade
Diabetic retinopathy (DR) is an inflammatory condition that affects the posterior of the eye; yet, there are limited published data on techniques measuring the expression of growth and inflammatory
Correlation of various serum biomarkers with the severity of diabetic retinopathy.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 60 REFERENCES
Vitreous levels of vascular cell adhesion molecule and vascular endothelial growth factor in patients with proliferative diabetic retinopathy: a case-control study.
TLDR
The low proportion of VCAM-1 in relation to total vitreous proteins observed in diabetic patients with PDR suggests that VC AM-1 is quenched by diabetic retina, and the direct correlation detected between VCam-1 and VEGF suggests that cellular adhesion and neovascularization may be linked processes.
Intercellular adhesion molecule-1 levels in plasma and vitreous from patients with vitreoretinal disorders.
TLDR
It is suggested that local cICAM-1 production, possibly from macrophages, may be of importance in the early phase of PVR and PDR by enhancing immune activation and inflammation.
Elevated concentrations of circulating adhesion molecules and their association with microvascular complications in insulin-dependent diabetes mellitus.
TLDR
It is concluded that, irrespective of actual metabolic control, serum concentrations of cICAM-1 and cVCam-1 but not cELAM- 1 are elevated in patients with IDDM, reflecting ongoing endothelial cell stimulation and leukocyte activation.
Soluble leucocyte adhesion molecules in diabetic retinopathy stimulate retinal capillary endothelial cell migration
TLDR
Data point to a functional role for leucocyte adhesion in the microvasculopathy of diabetic retinopathy and may have implications for the induction of retinal angiogenesis.
Monocyte Chemotactic Protein-1 in the Vitreous of Patients with Proliferative Diabetic Retinopathy
TLDR
The results suggest that MCP-1 may play a role in the development of the proliferative phase of PDR, and a significant association between M CP-1 levels in the vitreous and the degree of proliferative membrane is revealed.
[The role of adhesion molecules (ICAM-1 and E-selectin) in development of diabetic microangiopathies].
TLDR
Enhanced endothelium and leukocytes activation is associated with late complications in patients with diabetes mellitus type 1 at various stages of diabetic nephropathy and retinopathy.
Comparison of serum NO, TNF-alpha, IL-1beta, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus.
TLDR
The mean serum NO, sIL-2R, IL-8 and TNF-alpha levels increased with the stage of DR and the highest levels were found in patients with PDR, suggesting that these inflammatory cytokines may serve as therapeutic targets for endothelial cell targets during the treatment of diabetes.
...
1
2
3
4
5
...